Vycor Medical, Inc. (VYCO)
USD 0.12
(65.75%)
USD 0.12
(65.75%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.11 Million USD | 11.7% |
| 2022 | 993.92 Thousand USD | 14.55% |
| 2021 | 867.69 Thousand USD | -10.28% |
| 2020 | 967.09 Thousand USD | 64.78% |
| 2019 | 586.91 Thousand USD | 13.13% |
| 2018 | 518.81 Thousand USD | 62.95% |
| 2017 | 318.39 Thousand USD | 0.49% |
| 2016 | 316.85 Thousand USD | 0.35% |
| 2015 | 315.75 Thousand USD | -1.88% |
| 2014 | 321.78 Thousand USD | -44.35% |
| 2013 | 578.18 Thousand USD | -73.66% |
| 2012 | 2.19 Million USD | 34.19% |
| 2011 | 1.63 Million USD | 21.71% |
| 2010 | 1.34 Million USD | 20.99% |
| 2009 | 1.11 Million USD | 3.14% |
| 2008 | 1.07 Million USD | 225.73% |
| 2007 | 330.69 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.08 Million USD | -2.44% |
| 2024 Q2 | 1.06 Million USD | -2.02% |
| 2023 Q2 | 945.65 Thousand USD | -2.23% |
| 2023 FY | 1.11 Million USD | 11.7% |
| 2023 Q4 | 1.11 Million USD | -1.97% |
| 2023 Q3 | 1.13 Million USD | 19.77% |
| 2023 Q1 | 967.21 Thousand USD | -2.69% |
| 2022 Q1 | 924.5 Thousand USD | 6.55% |
| 2022 FY | 993.92 Thousand USD | 14.55% |
| 2022 Q3 | 960.26 Thousand USD | 6.1% |
| 2022 Q4 | 993.92 Thousand USD | 3.51% |
| 2022 Q2 | 905.02 Thousand USD | -2.11% |
| 2021 Q3 | 898.54 Thousand USD | -9.07% |
| 2021 Q2 | 988.21 Thousand USD | -1.92% |
| 2021 FY | 867.69 Thousand USD | -10.28% |
| 2021 Q1 | 1 Million USD | 4.18% |
| 2021 Q4 | 867.69 Thousand USD | -3.43% |
| 2020 Q1 | 790.63 Thousand USD | 34.71% |
| 2020 Q3 | 998.71 Thousand USD | 18.72% |
| 2020 FY | 967.09 Thousand USD | 64.78% |
| 2020 Q4 | 967.09 Thousand USD | -3.17% |
| 2020 Q2 | 841.26 Thousand USD | 6.4% |
| 2019 Q3 | 605.51 Thousand USD | 2.5% |
| 2019 FY | 586.91 Thousand USD | 13.13% |
| 2019 Q1 | 577.66 Thousand USD | 11.34% |
| 2019 Q2 | 590.74 Thousand USD | 2.26% |
| 2019 Q4 | 586.91 Thousand USD | -3.07% |
| 2018 FY | 518.81 Thousand USD | 62.95% |
| 2018 Q2 | 486.08 Thousand USD | 30.12% |
| 2018 Q4 | 518.81 Thousand USD | -3.9% |
| 2018 Q3 | 539.86 Thousand USD | 11.07% |
| 2018 Q1 | 373.55 Thousand USD | 17.33% |
| 2017 Q4 | 318.39 Thousand USD | -5.28% |
| 2017 FY | 318.39 Thousand USD | 0.49% |
| 2017 Q1 | 331.24 Thousand USD | 4.54% |
| 2017 Q2 | 316.89 Thousand USD | -4.33% |
| 2017 Q3 | 336.14 Thousand USD | 6.08% |
| 2016 FY | 316.85 Thousand USD | 0.35% |
| 2016 Q1 | 325.81 Thousand USD | 3.19% |
| 2016 Q4 | 316.85 Thousand USD | -45.59% |
| 2016 Q3 | 582.35 Thousand USD | 17.14% |
| 2016 Q2 | 497.15 Thousand USD | 52.59% |
| 2015 Q2 | 315.3 Thousand USD | -4.53% |
| 2015 FY | 315.75 Thousand USD | -1.88% |
| 2015 Q4 | 315.75 Thousand USD | -4.93% |
| 2015 Q3 | 332.14 Thousand USD | 5.34% |
| 2015 Q1 | 330.25 Thousand USD | 2.63% |
| 2014 Q2 | 2.66 Million USD | -2.19% |
| 2014 Q1 | 2.72 Million USD | 371.62% |
| 2014 FY | 321.78 Thousand USD | -44.35% |
| 2014 Q4 | 321.78 Thousand USD | -8.84% |
| 2014 Q3 | 352.99 Thousand USD | -86.76% |
| 2013 Q3 | 496.66 Thousand USD | -80.97% |
| 2013 Q2 | 2.61 Million USD | 2.92% |
| 2013 Q1 | 2.53 Million USD | 15.51% |
| 2013 FY | 578.18 Thousand USD | -73.66% |
| 2013 Q4 | 578.18 Thousand USD | 16.41% |
| 2012 Q3 | 2.06 Million USD | 27.28% |
| 2012 Q4 | 2.19 Million USD | 6.13% |
| 2012 Q1 | 1.64 Million USD | 0.43% |
| 2012 Q2 | 1.62 Million USD | -1.1% |
| 2012 FY | 2.19 Million USD | 34.19% |
| 2011 Q1 | 1.86 Million USD | 38.74% |
| 2011 Q2 | 1.82 Million USD | -2.35% |
| 2011 FY | 1.63 Million USD | 21.71% |
| 2011 Q3 | 1.63 Million USD | -10.24% |
| 2011 Q4 | 1.63 Million USD | 0.09% |
| 2010 FY | 1.34 Million USD | 20.99% |
| 2010 Q3 | 496.21 Thousand USD | 37.73% |
| 2010 Q2 | 360.27 Thousand USD | -36.23% |
| 2010 Q1 | 564.92 Thousand USD | -49.15% |
| 2010 Q4 | 1.34 Million USD | 170.91% |
| 2009 FY | 1.11 Million USD | 3.14% |
| 2009 Q4 | 1.11 Million USD | -10.58% |
| 2009 Q3 | 1.24 Million USD | 6.88% |
| 2009 Q2 | 1.16 Million USD | 6.03% |
| 2009 Q1 | 1.09 Million USD | 1.78% |
| 2008 FY | 1.07 Million USD | 225.73% |
| 2008 Q4 | 1.07 Million USD | 0.0% |
| 2007 FY | 330.69 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 60 Thousand USD | -1750.413% |
| SS Innovations International, Inc. | 8.21 Million USD | 86.491% |
| Össur hf. | 467.73 Million USD | 99.763% |
| Össur hf. | 467.73 Million USD | 99.763% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | 1.78 Million USD | 37.681% |
| BrainsWay Ltd. | 471 Thousand USD | -135.721% |
| BioElectronics Corporation | 14.83 Million USD | 92.514% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -147.006% |
| Zecotek Photonics Inc. | 3.22 Million USD | 65.54% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | 51.36 Million USD | 97.839% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 96.008% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 78.723% |
| Escalon Medical Corp. | 524.71 Thousand USD | -111.589% |
| Aurora Spine Corporation | 2.67 Million USD | 58.426% |
| NewCardio, Inc. | 3 Million USD | 62.992% |
| Avitar, Inc. | 5.26 Million USD | 78.914% |
| Vivos Inc. | - USD | -Infinity% |
| Theraclion SA | 1.95 Million EUR | 43.086% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -123.66% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -523.336% |
| Positron Corporation | 1.78 Million USD | 37.889% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -65.709% |
| Nanomix Corporation | 11.4 Million USD | 90.266% |
| Wellness Center USA, Inc. | 4.04 Million USD | 72.532% |
| Stratec SE | 156.16 Million USD | 99.289% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -430.496% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -1010.248% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 34.635% |
| Lombard Medical, Inc. | 32.29 Million USD | 96.562% |
| ALR Technologies Inc. | 19.26 Million USD | 94.237% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.935% |
| VMS Rehab Systems, Inc. | 133.52 USD | -831421.869% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -475.574% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 46.052% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 96.524% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -75.907% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Odyssey Group International, Inc. | 2.14 Million USD | 48.232% |
| IR-Med Inc. | 161 Thousand USD | -589.595% |
| Polarean Imaging plc | 216.38 Thousand USD | -413.089% |
| ECGI Holdings, Inc. | 3.17 Million USD | 64.99% |
| Capital Group Holdings, Inc. | 4944.00 USD | -22356.472% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -38.84% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -389.092% |
| Urologix, Inc. | 5.33 Million USD | 79.182% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 71.017% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 73.661% |
| Qualis Innovations, Inc. | 9102.00 USD | -12097.847% |
| Smith & Nephew plc | 3.07 Billion USD | 99.964% |
| NIOX Group Plc | 1.4 Million USD | 20.714% |
| Fuse Medical, Inc. | 1.99 Million USD | 44.311% |
| Broncus Holding Corporation | 2.35 Million USD | 52.843% |
| Brain Scientific Inc. | 2.86 Million USD | 61.227% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 95.122% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -2645.285% |